Today's top medical abstracts
Oncology
Become a Member Today!
Email
Password
Remember me
Forgot your Password?

Invite Code?

Home
General Oncology
For Practicing
Oncologists
Conferences
Jobs
Newsletters
My Library
Topics in
Oncology
        Alternative Therapies
        Anemia/Polycythemia
        BMT/SCT
        Basic Science/Genetics
        Bone/Cartilage
        Breast
        Carcinogenesis
        Coagulation/Bleeding Dz
        Colorectal Cancer/Polyps
        Dermatologic Oncology
        Diagnostics/Radiology
        Economics of Medicine
        Endocrine Oncology
        GI Oncology
        Gynecologic Oncology
        Head and Neck
        Hepatobiliary/Pancreas
        Leukemia/Lymphoma
        Lung/Thoracic Oncology
        Myeloproliferative Dz
        Neurologic Oncology
        Pain/Palliative Care
        Pediatric Heme/Oncology
        Pharmacology/Therapy
        Popular Press
        Renal/Urologic
        Side Effects
        Soft Tissue/Sarcoma
        Transfusion Medicine
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
 
Sponsor
For Practicing Oncologists
Providers Satisfied with Carriers/MACs
Roberta Buell, MBA, Sausalito Healthcare Partners
Cancer Science: Mutations in the ALK Receptor Kinase cause Neuroblastoma
Sara Hartley, MDLinx Oncology
Technology Advances: Laser Microscopy Offers Vista of Real-Time Cell Movements
Dorothy J. Schirf, MD, MDLinx Oncology
  See all
gastrointestional stromal tumors; PDGFR gene mutation and protein expression Article Summary

Click the title below to leave the MDLinx Network and go to the Journal's Website
PDGFRα gene mutation and protein expression in gastrointestinal stromal tumors
Oncology (Karger), 06/20/08
Print     Email This Article     Save in My Library   Free Abstract
Chang HM et al. - In a trial to evaluate the prevalence of PDGFRα mutations and corresponding protein expression in gastrointestinal tumors (GISTs) to determine their usefulness in obtaining a prognosis, it was shown that PDGFRα mutations in GISTs were rare in this Korean population. Although localized GISTs with PDGFRα mutations showed relatively good prognosis after resection, the difference was not statistically significant

Methods
  • Genomic DNA was extracted from paraffin-embedded tumor tissues from 194 GISTs
  • Exons 12, 14 and 18 of the PDGFRα were amplified and sequenced
  • Immunohistochemical staining was performed in 179 pts

Results
  • Mutations in PDGFRα were detected in 6 pts, and were observed solely in KIT wild-type GISTs
  • Among the 6 pts with PDGFRα gene mutations, 5 pts with localized GISTs showed no relapse after resection during the 19- to 80-month follow-up period
  • Intensity of PDGFRα expression was classified as 0 in 26, 1+ in 69, 2+ in 71, and 3+ in 13 pts
  • Levels of PDGFRα expression showed no correlation with relapse-free survival

Sponsor
Read a Different Specialty
Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pediatrics
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology
Profession Index
Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2008 MDLinx, Inc.